Stryde Research is heading to ACR Convergence 2026, the American College of Rheumatology’s annual meeting, in Orlando, Florida. We will be on the exhibit floor at booth 2633 from Sunday, November 8 through Tuesday, November 10, with four members of our team ready to talk rheumatology, autoimmune research, and cell and gene therapy. Come find …
Read more “Stryde Research is exhibiting at ACR Convergence 2026 in Orlando”
At the Global Site Solutions Summit in Orlando, October 15 to 18, 2026, sponsors and CROs kept returning to one theme: partnership with clinical research sites. They asked for prompt communication about delays, real enrollment numbers, early conversations about budget and staffing, and clear information on site equipment. They also talked about taking administrative work …
Read more “What sponsors and CROs asked of sites at the Global Site Solutions Summit 2026”
October is Eczema Awareness Month. At Stryde Research, our team works with people living with eczema inside the dermatology practices where they already get care. Eczema, also called atopic dermatitis, causes dry, itchy, inflamed skin. It is not contagious. And what patients tell us most isn’t about how it looks. It’s about what eczema takes …
Read more “Eczema awareness month: what eczema really takes”
Stryde Research sites were recently named among the top enrolling sites in two ongoing studies: a multinational lupus clinical trial and an atopic dermatitis (eczema) study. Both recognitions came from study teams in updates to participating investigators. Each ranking counts patients enrolled. What they reflect is how our sites operate, and the trust patients already …
Read more “Stryde Research named a top enrolling site, again”
On September 26th, our patient recruitment team spent the morning at the 2026 Walk to End Lupus Now, Dallas, hosted by the Lupus Foundation of America at Klyde Warren Park. We came to listen and hand out a few survival kits. We left with a clearer picture of who shows up for lupus, why they …
Read more “What we learned at the 2026 Walk to End Lupus Now, Dallas”
Stryde Research will attend the Global Site Solutions Summit in Orlando, Florida, from October 15 to 18, 2026. Dr. Haein Kim and Edward Olko from our team will be there to meet with sponsors and CROs who are planning site selection or managing studies that are behind on enrolment. Stryde runs clinical research sites inside …
Read more “Stryde Research at the Global Site Solutions Summit 2026”
Stryde Research is heading to Cell and Gene Meeting on the Mesa, October 5 to 7 in Phoenix, Arizona. Edward Olko, our head of business development, will be there all three days to meet with sponsors, CROs, and physicians working in cell and gene therapy. If you’re attending, come find him and say hello. Event …
Read more “Stryde Research is heading to Cell and Gene Meeting on the Mesa 2026”
Stryde Research is joining the Lupus Foundation of America’s Walk to End Lupus Now on Saturday, September 26th at Klyde Warren Park in Dallas. We will have a table on site, a team walking the route, and giveaways for anyone who stops by. Come find us and say hello. Event details Find our table Look …
Read more “Stryde Research is walking at the 2026 Dallas Walk to End Lupus Now”
Biotech trial site partnerships might sound like a complex topic, but their role in healthcare is straightforward and impactful. Essentially, these partnerships involve collaboration between biotech companies and clinical trial sites to bring new medicines and therapies to the market faster. Imagine a world where finding a cure for challenging diseases becomes quicker. That’s the …
Read more “Finding Innovative Solutions with Biotech Trial Site Partnerships”
Clinical trials are a crucial part of the drug development process. However, these trials have historically lacked diversity, with underrepresented populations being less likely to participate. The FDA has issued guidance on diversity in clinical trials, emphasizing the importance of including diverse populations in clinical research studies. At Stryde, we are committed to partnering with …
Read more “Diversity in Research: Partnering with Pharma for New FDA Guidance”